Alliance Pharma has seen profits and sales double after it acquired a range of products from rival Alliance Pharma The current year . The firm's sales rose to $121.3m ( £97.5m ), a 102% increase, with profits rising to £97.5m . Alliance will now focus on developing three of its core brands — Kelo-cote , MacuShield and Diclectin — on an international level, according to Chairman Andrew Smith .
Alliance Pharma has seen profits and sales double after it acquired a range of products from rival Sinclair Pharma last year. The firm's sales rose to £97.5m ($121.3m), a 102% increase, with profits rising to £22.2m. Alliance will now focus on developing three of its core brands — Kelo-cote, MacuShield and Diclectin — on an international level, according to Chairman Andrew Smith.